MedPath

Reduced incidence of nausea and vomiting (PONV) in sevoflurane anaesthesia due to low-dose propofol infusio

Not Applicable
Recruiting
Conditions
M16.1
K40.9
Other primary coxarthrosis
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
Registration Number
DRKS00008568
Lead Sponsor
Park-Klinik WeissenseeAbteilung Anästhesiologie Intensivmedizin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
686
Inclusion Criteria

Patients undergoing elective surgery under general anaesthesia

Endotracheal intubation

Minimum age of 18 years

ASA-classification I-III

Minimum duration of operation 30 minutes

Good knowledge of German for understanding

Exclusion Criteria

Lack of willingness to accept storage and transfer of pseudonymised health data
Emergency surgery
Pregnancy
Inoperable regarding the ASA-classification
Artificial ventilation postoperatively
Lack of an informed consent
Age under 18 years
Participation in an other study during the last three month
Mental disorders
History of an adverse reaction to study medication

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
prevalence and severity of PONV (acquired by postoperative questionnaire, day of surgery, first and second postoperative day)
Secondary Outcome Measures
NameTimeMethod
sevoflurane concentration( Vol%exp) at a given depth of anaesthesia (Narcotrend-signal: D2-E0) and a fix propofol dosage (1 µg/ml, TCI-modus) [intraoperative measurement]<br><br>use of vasoactive substances such as norepinephrine [intraoperative measurement and recovery room]<br><br>pain level and need in analgesics postoperatively [recovery room, day of surgery, first and second postoperative day]<br><br>duration of stay in recovery room [postoperative measurement]<br><br>cognitive function [1 day preoperatively, recovery room, first and second postoperative day]<br><br><br>
© Copyright 2025. All Rights Reserved by MedPath